These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35769171)

  • 1. Perceived Ability to Treat Opioid Use Disorder in West Virginia.
    Sheppard AB; Young JC; Davis SM; Moran GE
    J Appalach Health; 2021; 3(2):32-42. PubMed ID: 35769171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prescribing Practices of Nurse Practitioners and Physician Assistants Waivered to Prescribe Buprenorphine and the Barriers They Experience Prescribing Buprenorphine.
    Andrilla CHA; Jones KC; Patterson DG
    J Rural Health; 2020 Mar; 36(2):187-195. PubMed ID: 31650634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Geographic Distribution of Providers With a DEA Waiver to Prescribe Buprenorphine for the Treatment of Opioid Use Disorder: A 5-Year Update.
    Andrilla CHA; Moore TE; Patterson DG; Larson EH
    J Rural Health; 2019 Jan; 35(1):108-112. PubMed ID: 29923637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perceptions of buprenorphine barriers and efficacy among nurse practitioners and physician assistants.
    Andraka-Christou B; Page C; Schoebel V; Buche J; Haffajee RL
    Addict Sci Clin Pract; 2022 Aug; 17(1):43. PubMed ID: 35945636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies to recruit rural primary care providers to implement a medication for opioid use disorder (MOUD) focused integrated care model.
    Cloutier RM; Cole ES; McDonough BL; Lomauro DA; Miller JP; Talbert AL; Bear TM; Bridges NC; Foulds AL; Taber R; Gordon AJ; Cochran GT; Kmiec J; Donohue JM; Kelley D; DiDomenico E; Adair D; Pringle JL
    Implement Res Pract; 2023; 4():26334895231152808. PubMed ID: 37091535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing waivered and non-waivered physician barriers to treating patients with substance use disorders: a cross-sectional Kentucky pilot.
    Thompson RA; Johnson D; Kizewski AL; Baier L; Coburn K; White J; Bunn T; Fletcher EL
    J Addict Dis; 2022; 40(4):518-526. PubMed ID: 35238283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Primary Care in Improving Access to Medication-Assisted Treatment for Rural Medicaid Enrollees with Opioid Use Disorder.
    Cole ES; DiDomenico E; Cochran G; Gordon AJ; Gellad WF; Pringle J; Warwick J; Chang CH; Kim JY; Kmiec J; Kelley D; Donohue JM
    J Gen Intern Med; 2019 Jun; 34(6):936-943. PubMed ID: 30887440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A bridge too far? Distance to waivered physicians and utilization of buprenorphine treatment for opioid use disorder in West Virginia Medicaid.
    Saloner B; Landis RK; Jayakrishnan R; Stein BD; Barry CL
    Subst Abus; 2022; 43(1):682-690. PubMed ID: 35099362
    [No Abstract]   [Full Text] [Related]  

  • 9. Rural access to MAT in Pennsylvania (RAMP): a hybrid implementation study protocol for medication assisted treatment adoption among rural primary care providers.
    Cochran G; Cole ES; Warwick J; Donohue JM; Gordon AJ; Gellad WF; Bear T; Kelley D; DiDomenico E; Pringle J
    Addict Sci Clin Pract; 2019 Aug; 14(1):25. PubMed ID: 31366408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanding Opioid Use Disorder Treatment in Priority Areas: The Role of Certified Nurse-Midwives.
    Kane C; Topmiller M
    J Midwifery Womens Health; 2022 May; 67(3):314-320. PubMed ID: 35506768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the question of financial incentives for training amongst non-adopters of MOUD in rural primary care.
    Haggerty T; Turiano NA; Turner T; Dekeseredy P; Sedney CL
    Addict Sci Clin Pract; 2022 Dec; 17(1):72. PubMed ID: 36517926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Access to MAT: Participants' Experiences With Transportation, Non-Emergency Transportation, and Telehealth.
    Boyd J; Carter M; Baus A
    J Prim Care Community Health; 2024; 15():21501319241233198. PubMed ID: 38420885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barriers and perceived usefulness of an ECHO intervention for office-based buprenorphine treatment for opioid use disorder in North Carolina: A qualitative study.
    Shea CM; Gertner AK; Green SL
    Subst Abus; 2021; 42(1):54-64. PubMed ID: 31809679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of Medicaid expansion on use of opioid agonist treatment and the role of provider capacity constraints.
    Gertner AK; Robertson AG; Jones H; Powell BJ; Silberman P; Domino ME
    Health Serv Res; 2020 Jun; 55(3):383-392. PubMed ID: 32166761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barriers and Facilitators to DATA Waivered Providers Prescribing Buprenorphine: A Qualitative Analysis Applying the Theory of Planned Behavior.
    Bapat S; Washburn M; Tata V; Fleming M; Abughosh SM; Essien EJ; Thornton D
    Subst Use Misuse; 2022; 57(12):1761-1771. PubMed ID: 35993387
    [No Abstract]   [Full Text] [Related]  

  • 16. Implications of Increased Access to Buprenorphine for Medical Providers in Rural Areas: A Review of the Literature and Future Directions.
    Gregory HM; Hill VM; Parker RW
    Cureus; 2021 Nov; 13(11):e19870. PubMed ID: 34976492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survey of Barriers and Facilitators to Prescribing Buprenorphine and Clinician Perceptions on the Drug Addiction Treatment Act of 2000 Waiver.
    Lanham HJ; Papac J; Olmos DI; Heydemann EL; Simonetti N; Schmidt S; Potter JS
    JAMA Netw Open; 2022 May; 5(5):e2212419. PubMed ID: 35552721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Supply of Physicians Waivered to Prescribe Buprenorphine for Opioid Use Disorders in the United States: A State-Level Analysis.
    Knudsen HK
    J Stud Alcohol Drugs; 2015 Jul; 76(4):644-54. PubMed ID: 26098042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overcoming Barriers to Prescribing Buprenorphine for the Treatment of Opioid Use Disorder: Recommendations from Rural Physicians.
    Andrilla CHA; Moore TE; Patterson DG
    J Rural Health; 2019 Jan; 35(1):113-121. PubMed ID: 30339720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescribing patterns of buprenorphine waivered physicians.
    Thomas CP; Doyle E; Kreiner PW; Jones CM; Dubenitz J; Horan A; Stein BD
    Drug Alcohol Depend; 2017 Dec; 181():213-218. PubMed ID: 29096292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.